Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Practical Laboratory Medicine|October 7, 2022
Development of quantified HIV-1 antigen panel for evaluating HIV Ag/Ab combination tests using the RT-qPCR methodShigeru Kusagawa, Isao Hamaguchi, Masashi Tatsumi
American Journal of Primatology|January 30, 2020
Blastogenic response of peripheral blood lymphocytes to mitogens in cynomolgus monkeys (Macaca fascicularis)Masashi Tatsumi, Tooru Fujiwara, Masanori Hayami
American Journal of Primatology|January 30, 2020
Identification of cynomolgus T lymphocytes by acid alpha-naphthyl acetate esterase staining and spontaneous erythrocyte rosette formationMasashi Tatsumi, Chiharu Morita, Tooru Fujiwara, et al.
Japanese Journal of Infectious Diseases|February 24, 2006
Development of a real-time PCR assay for detection and quantification of Francisella tularensisOsamu Fujita, Masashi Tatsumi, Kiyoshi Tanabayashi, et al.
Retrovirology|February 26, 2013
DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibitionTakayoshi Koyama, Binlian Sun, Kenzo Tokunaga, et al.
Journal of Virology|May 22, 2002
Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressorsMinoru Tobiume, Mikako Takahoko, Takeshi Yamada, et al.
Microbes and Infection|April 28, 2004
Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entryTakayuki Harada, Masashi Tatsumi, Hidehiro Takahashi, et al.
AIDS (London, England)|September 23, 2003
High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombinationYutaka Takebe, Kazushi Motomura, Masashi Tatsumi, et al.
AIDS Research and Human Retroviruses|October 31, 2002
Isolation and characterization of an infectious HIV type 1 molecular clone from a patient with primary infectionHiroaki Takeuchi, Youichi Suzuki, Masashi Tatsumi, et al.
Vaccine|September 15, 2022
Engineered flavivirus vaccines control induction of crossreactive infection-enhancing and -neutralizing antibodiesAtsushi Yamanaka, Pimploy Rattanaamnuaychai, Mami Matsuda, et al.
Pageof 4